// App-Quantinova.ai

3362 : Expression of CD44v9, a cancer stem cell marker, in human hepatocellular carcinoma

Researchers

Presenter

  • Fumitaka Wada

Principal Investigators

  • N/A

Medical Centers

  • Division of Gastroenterology, Department of Medicine, Kurume University, Kurume, Fukuoka, Japan.

Locations

  • Japan

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Liver cancer

  • Ulcerative colitis

  • Solid malignancies

Biomarkers

  • Cluster of Differentiation 44

  • Proto-oncogene tyrosine-protein kinase ROS

  • Glutathione

Drug/Treatment

  • Sulfasalazine

  • glutathione

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved